In the decade and a half that has passed since the completion of the Human Genome Project, the genomic revolution has spurred an immeasurable level of excitement and support surrounding the promise of personalized medicine, setting high expectations for a new era of health care and rapidly transforming the field into a multi-billion dollar industry. While realizing the enormous potential of personalized medicine has turned out to be neither quick nor easy, recent scientific and technological progress has been impressive, pointing to a possible tipping point.
The Business of Personalized Medicine Summit brings together top executives from across multiple stakeholder perspectives for a look at the state of the industry past, present, and future. Through a series of thought-provoking discussions, the BPM Summit:
Explores solutions to the obstacles and limitations that have kept us from realizing the full promise of personalized medicine to date, as well as emerging challenges we must overcome to continue advancing medicine and the marketplace
Celebrates the extraordinary achievements in innovation and collaboration that have led us to where we are now while looking ahead to promising new advances underway
Examines the complexities, trends, and opportunities of an evolving personalized medicine landscape driven by the convergence of science and technology, including implications for the future of business and policy in the field
Forums for discussing personalized medicine have focused, for the most part, on relatively specialized areas such as underlying technologies, financing, regulatory pathways, or payment issues. The BPM Summit attempts to address cross-sections of such issues with a clear eye toward modeling sustainable business models for all entities already engaged in personalized medicine as well as those that seek to enter the field. The BPM Summit aims to set itself apart from other conferences by focusing on the business challenges, trends, and opportunities within the personalized medicine industry, while also examining the potential implications for research and development and healthcare delivery.
Join us in South San Francisco on Thursday, February 27, 2020, for another can’t-miss day of networking and thought leadership!
Business, legal, and health care professionals interested in industry leaders' real-world experience on the current state of personalized medicine and where growth and opportunity exist
Business, legal, and health care professionals interested in discussions regarding the regulatory framework for diagnostics and targeted therapies
Executives and entrepreneurs interested in hearing diverse perspectives on both the development and delivery of personalized medicine therapies
Payors interested in the current status and future possibilities regarding reimbursement of personalized medicine technologies
Corporate counsel in life sciences and health care provider organizations
Health care professionals working in the field of personalized medicine
Health care and life sciences investors